JNJ-61187191

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameJNJ-61187191
Drug Alias NameRespiratory syncytial virus acvvineAd35.RSV.FA2JNJ-61187191JNJ-61187191AAAAd35-RSV-FA2
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRespiratory Syncytial Virus InfectionsRespiratory Tract Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCrucell Holland Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrucell Holland Bv
Active IndicationsN/A
Inactive IndicationsRespiratory Syncytial Virus InfectionsRespiratory Tract Infections

Other Information

ATC CodeN/A
Related LinksN/A